Notification close image
No new Notification messages
card image
Seshaasai Technologies Ltd IPO
Apply for the Seshaasai Technologies Ltd IPO through UPI in Just minutes
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

0

524572

PHARMAID

img img img img
No Data Available

Pharmaids Pharmaceuticals Share Price Update

As of the latest trading session, Pharmaids Pharmaceuticals share price is currently at ₹ 44.78, which is up by ₹ 0.97 from its previous closing. Today, the stock has fluctuated between ₹ 42.85 and ₹ 44.82. Over the past year, Pharmaids Pharmaceuticals has achieved a return of -38.78 %. In the last month alone, the return has been -8.04 %. Read More...

Investment Returns

Over 1 Month [-]% Over 3 Months [-]% Over 6 Months [-]% Over 1 Year [-]%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

Pharmaids Pharmaceuticals fundamentals


  • Market cap (Cr)

    [-]

  • P/E Ratio (TTM)

    [-]

  • Beta

    [-]

  • Book Value / share

    [-]

  • Return on equity

    [-]%

  • EPS (TTM)

    [-]

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    [-]

info icon alternate text
  • Market cap (Cr)

    157.90

  • P/E Ratio (TTM)

    -14.50

  • Beta

    0.20

  • Book Value / share

    16.38

  • Return on equity

    0.00%

  • EPS (TTM)

    0.00

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    -1.65

info icon alternate text

Pharmaids Pharmaceuticals Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars SEP 2025 (Values in Cr)
Revenue 5.97
Operating Expense 11.62
Net Profit -1.65
Net Profit Margin (%) -27.63
Earnings Per Share (EPS) -0.47
EBITDA -1.25
Effective Tax Rate (%) 29.18
Particulars JUN 2025 (Values in Cr)
Revenue 1.12
Operating Expense 7.15
Net Profit -4.36
Net Profit Margin (%) -389.28
Earnings Per Share (EPS) -1.24
EBITDA -4.53
Effective Tax Rate (%) 23.37
Particulars MAR 2025 (Values in Cr)
Revenue 0.13
Operating Expense 4.92
Net Profit -3.06
Net Profit Margin (%) -2353.84
Earnings Per Share (EPS) -0.86
EBITDA -1.68
Effective Tax Rate (%) 19.04
Particulars DEC 2024 (Values in Cr)
Revenue 1.21
Operating Expense 3.06
Net Profit -1.59
Net Profit Margin (%) -131.40
Earnings Per Share (EPS) -0.45
EBITDA -1.73
Effective Tax Rate (%) 13.51
Particulars SEP 2024 (Values in Cr)
Revenue 0.83
Operating Expense 2.01
Net Profit -1.01
Net Profit Margin (%) -121.68
Earnings Per Share (EPS) -0.29
EBITDA -1.13
Effective Tax Rate (%) 15.12
Particulars MAR 2025 (Values in Cr)
Revenue 2.34
Operating Expense 11.95
Net Profit -7.28
Net Profit Margin (%) -311.11
Earnings Per Share (EPS) -2.06
EBITDA -6.23
Effective Tax Rate (%) 15.25
Particulars MAR 2024 (Values in Cr)
Revenue 0.03
Operating Expense 6.91
Net Profit -4.95
Net Profit Margin (%) -16500.00
Earnings Per Share (EPS) -2.18
EBITDA -5.58
Effective Tax Rate (%) 18.71
Particulars MAR 2023 (Values in Cr)
Revenue 0.00
Operating Expense 9.91
Net Profit -7.56
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -5.86
EBITDA -9.89
Effective Tax Rate (%) 23.71
Particulars MAR 2022 (Values in Cr)
Revenue 3.94
Operating Expense 3.81
Net Profit 0.15
Net Profit Margin (%) 3.80
Earnings Per Share (EPS) 0.14
EBITDA 0.15
Effective Tax Rate (%) 0.00
Particulars MAR 2021 (Values in Cr)
Revenue 8.55
Operating Expense 8.49
Net Profit 0.09
Net Profit Margin (%) 1.05
Earnings Per Share (EPS) 0.09
EBITDA 0.13
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Book Value / Share 16.82
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.36
EBITDA Margin -65.50
Particulars MAR 2024 (Values in Cr)
Book Value / Share 20.43
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.09
EBITDA Margin -81.54
Particulars MAR 2023 (Values in Cr)
Book Value / Share 10.31
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2022 (Values in Cr)
Book Value / Share 8.44
ROE % 1.36
ROCE % 1.36
Total Debt to Total Equity 0.00
EBITDA Margin 3.81
Particulars MAR 2025 (Values in Cr)
Book Value / Share 18.09
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.39
EBITDA Margin -266.67
Particulars MAR 2024 (Values in Cr)
Book Value / Share 20.15
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.14
EBITDA Margin -18600.00
Particulars MAR 2023 (Values in Cr)
Book Value / Share 10.46
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2022 (Values in Cr)
Book Value / Share 8.44
ROE % 1.36
ROCE % 1.36
Total Debt to Total Equity 0.00
EBITDA Margin 3.81
Particulars MAR 2021 (Values in Cr)
Book Value / Share 8.30
ROE % 0.82
ROCE % 0.82
Total Debt to Total Equity 0.00
EBITDA Margin 1.52
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 2.14
Total Assets 119.85
Total Liabilities 119.85
Total Equity 55.04
Share Outstanding 35267812
Price to Book Ratio 3.80
Return on Assets (%) -8.99
Return on Capital (%) -11.94
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 4.80
Total Assets 91.34
Total Liabilities 91.34
Total Equity 70.49
Share Outstanding 35267812
Price to Book Ratio 2.58
Return on Assets (%) -8.72
Return on Capital (%) -10.51
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 12.75
Total Assets 24.58
Total Liabilities 24.58
Total Equity 22.46
Share Outstanding 21443819
Price to Book Ratio 2.09
Return on Assets (%) -30.72
Return on Capital (%) -33.64
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.40
Total Assets 11.11
Total Liabilities 11.11
Total Equity 8.67
Share Outstanding 10268819
Price to Book Ratio 1.48
Return on Assets (%) 1.30
Return on Capital (%) 1.67
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.46
Total Assets 118.68
Total Liabilities 118.68
Total Equity 63.78
Share Outstanding 35267812
Price to Book Ratio 3.80
Return on Assets (%) -6.13
Return on Capital (%) -7.05
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 2.45
Total Assets 85.00
Total Liabilities 85.00
Total Equity 71.06
Share Outstanding 35267812
Price to Book Ratio 2.58
Return on Assets (%) -5.82
Return on Capital (%) -5.92
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 12.75
Total Assets 24.54
Total Liabilities 24.54
Total Equity 22.42
Share Outstanding 21486234
Price to Book Ratio 2.09
Return on Assets (%) -30.77
Return on Capital (%) -33.69
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.40
Total Assets 11.11
Total Liabilities 11.11
Total Equity 8.67
Share Outstanding 10268819
Price to Book Ratio 1.48
Return on Assets (%) 1.30
Return on Capital (%) 1.67
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.20
Total Assets 9.11
Total Liabilities 9.11
Total Equity 8.52
Share Outstanding 10268819
Price to Book Ratio 1.35
Return on Assets (%) 1.02
Return on Capital (%) 1.09
Particulars MAR 2025 (Values in Cr)
Net Income -17.27
Cash from Operations -13.92
Cash from Investing -12.02
Cash from Financing 23.35
Net change in Cash -2.65
Free Cash Flow -1.44
Particulars MAR 2024 (Values in Cr)
Net Income -15.62
Cash from Operations -10.61
Cash from Investing -74.99
Cash from Financing 77.65
Net change in Cash -7.95
Free Cash Flow 12.24
Particulars MAR 2023 (Values in Cr)
Net Income -9.90
Cash from Operations -4.01
Cash from Investing -4.94
Cash from Financing 21.30
Net change in Cash 12.34
Free Cash Flow -2.34
Particulars MAR 2022 (Values in Cr)
Net Income 0.14
Cash from Operations -0.25
Cash from Investing 0.46
Cash from Financing 0.00
Net change in Cash 0.20
Free Cash Flow -0.25
Particulars MAR 2025 (Values in Cr)
Net Income -8.58
Cash from Operations -7.72
Cash from Investing -18.90
Cash from Financing 24.63
Net change in Cash -1.99
Free Cash Flow 1.31
Particulars MAR 2024 (Values in Cr)
Net Income -6.08
Cash from Operations -3.44
Cash from Investing -72.50
Cash from Financing 65.65
Net change in Cash -10.29
Free Cash Flow 12.92
Particulars MAR 2023 (Values in Cr)
Net Income -9.90
Cash from Operations -4.01
Cash from Investing -4.94
Cash from Financing 21.31
Net change in Cash 12.35
Free Cash Flow -2.34
Particulars MAR 2022 (Values in Cr)
Net Income 0.14
Cash from Operations -0.25
Cash from Investing 0.46
Cash from Financing 0.00
Net change in Cash 0.20
Free Cash Flow -0.25
Particulars MAR 2021 (Values in Cr)
Net Income 0.08
Cash from Operations 0.40
Cash from Investing -0.22
Cash from Financing 0.00
Net change in Cash 0.17
Free Cash Flow 0.40
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 23.82 11.68 1.23 182.54 23.35 / 53.83
BLISS GVS PHARMA LTD 167.30 16.15 1.56 1769.85 105.05 / 195.85
CIPLA LTD 1312.85 22.30 3.22 106048.24 1283.00 / 1672.20
FERMENTA BIOTECH LIMITED 317.45 8.34 2.38 934.29 219.00 / 449.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 23.82 19.37 3.32 182.54 23.35 / 53.83
AMRUTAJAN HEALTH LTD 591.00 30.14 4.99 1708.62 548.05 / 789.95
ASTRAZENECA PHARMA IND LT 8340.95 90.20 26.09 20852.38 6501.60 / 10653.05
BLISS GVS PHARMA LTD 167.30 22.58 1.60 1769.85 105.05 / 195.85

Pharmaids Pharmaceuticals shareholding pattern

Holding

67.01%
32.98%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

Pharmaids Pharmaceuticals Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
44.78 2.23 redarrow
red-green-graph indicator
2 Bearish
14 Bullish
  • 5 Days 44.30
  • 26 Days 46.60
  • 10 Days 45.20
  • 50 Days 47.90
  • 12 Days 45.40
  • 100 Days 50.70
  • 20 Days 46.20
  • 200 Days 54.30
43.90 PIVOT

First Support

42.36

First Resistance

45.34

Second Support

40.92

Second Resistance

46.88

Third Support

39.38

Third Resistance

48.32

RSI

39.78

ADX

44.72

MACD

-1.17

Williams % R

-80.96

Commodity Channel Index (CCI)

-188.08

Date

2026-01-27

Week

1750.00

Same Day

1660.00

Month

2465.00

1 Year

0.20

3 Year

0.08

Over 1 Month

-8.04%

down

Over 1 Year

-38.78%

down

Over 3 Months

-13.62%

down

Over 3 Years

15.06%

down

Over 6 Months

-33.13%

down

Over 5 Years

29.88%

down

Pharmaids Pharmaceuticals Corporate Actions

Top Gainers

Pharmaids Pharmaceuticals Share Price

Pharmaids Pharmaceuticals Limited, incorporated in March, 1989 at Hyderabad, Telangana were suppliers of Quality Grade range of speciality chemicals, skin care, hospital care and generic products in the areas of Orthopedic, Neuro and Gastro etc. The technical team used quality proven chemical compounds and standard processing methods maintaining proper hygiene standards.The Company is engaged in the business of contract research and manufacturing services.

Emergent Bio Naturals Limited (EBNL) was amalgamated with the Company in 2019-20 and the Scheme of Amalgamation was effective on September 27, 2019. Pursuant to the Scheme, 69,05,734 Equity Shares were allotted to Shareholders of Emergent Bio Naturals Limited on November 27, 2019.

The Company acquired 25.5% stake as 1st tranche in Anugraha Chemicals, a Partnership Firm, registered under Karnataka Partnership Rules, 1954 on February 1, 2023. Further, it acquired Adita Bio Sys Private Limited, making it wholly owned subsidiary of the Company.

Company acquired additional 28.50% of partnership interest in Anugraha Chemicals totalling to 54% partnership interest and became the subsidiary of the Company in 2024. Company acquired an additional 12.5% partnership interest in Anugraha Chemicals , thereby increasing its total partnership interest to 66.50% in FY25.

Parent organization Indian Private
NSE symbol [-]
Founded 1989
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Pharmaids Pharmaceuticals Ltd?

Answer Field

Pharmaids Pharmaceuticals Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 44.78 as on Jan 28 2026 03:29 PM.

What is the Market Cap of Pharmaids Pharmaceuticals Ltd Share?

Answer Field

The market cap of Pharmaids Pharmaceuticals Ltd for NSE ₹ 0.00 & for BSE ₹ 157.90 as on Jan 28 2026 03:29 PM.

What is the 52 Week High and Low of Pharmaids Pharmaceuticals Ltd?

Answer Field

The 52 Week High and Low of Pharmaids Pharmaceuticals Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 76.21 and ₹ 42.00.

What is 1 year return for Pharmaids Pharmaceuticals Ltd?

Answer Field

The 1 year returns on the stock has been -38.78%.

What is the P/E Ratio of Pharmaids Pharmaceuticals Ltd Share?

Answer Field

As on Jan 28 2026 03:29 PM the price-to-earnings (PE) ratio for Pharmaids Pharmaceuticals Ltd share is -14.50.

What is the PB ratio of Pharmaids Pharmaceuticals Ltd Share?

Answer Field

As on Jan 28 2026 03:29 PM, the price-to-book (PB) ratio for Pharmaids Pharmaceuticals Ltd share is 16.38.

How to Buy Pharmaids Pharmaceuticals Ltd Share?

Answer Field

You can trade in Pharmaids Pharmaceuticals Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Pharmaids Pharmaceuticals Ltd Share on Bajaj Broking App?

Answer Field

To buy Pharmaids Pharmaceuticals Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Pharmaids Pharmaceuticals Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59